Isaac E. Ciechanover Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Isaac E. Ciechanover.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Isaac E. Ciechanover. Isaac E. Ciechanover is Chief Executive Officer in Atara Biotherapeutics, Inc. ($ATRA).
Latest Insider Trading Transactions of Isaac E. Ciechanover
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 31 2019 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 23.70 | 1,500 | 35,550 | 290,687 | 292.2 K to 290.7 K (-0.51 %) |
May 31 2019 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 22.72 | 1,425 | 32,376 | 292,187 | 293.6 K to 292.2 K (-0.49 %) |
May 31 2019 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 23.30 | 725 | 16,893 | 293,612 | 294.3 K to 293.6 K (-0.25 %) |
May 31 2019 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 22.85 | 2,200 | 50,270 | 294,337 | 296.5 K to 294.3 K (-0.74 %) |
May 15 2019 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 24.92 | 3,900 | 97,188 | 296,537 | 300.4 K to 296.5 K (-1.30 %) |
May 15 2019 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 24.95 | 400 | 9,980 | 300,437 | 300.8 K to 300.4 K (-0.13 %) |
May 15 2019 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 24.23 | 3,500 | 84,805 | 300,837 | 304.3 K to 300.8 K (-1.15 %) |
Apr 29 2019 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 33.47 | 3,900 | 130,533 | 304,337 | 308.2 K to 304.3 K (-1.27 %) |
Apr 29 2019 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 33.99 | 300 | 10,197 | 308,237 | 308.5 K to 308.2 K (-0.10 %) |
Apr 29 2019 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 33.57 | 3,600 | 120,852 | 308,537 | 312.1 K to 308.5 K (-1.15 %) |
Apr 12 2019 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 36.27 | 3,900 | 141,453 | 312,137 | 316 K to 312.1 K (-1.23 %) |
Apr 12 2019 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 37.04 | 3,900 | 144,456 | 316,037 | 319.9 K to 316 K (-1.22 %) |
Mar 18 2019 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 38.73 | 3,900 | 151,047 | 327,737 | 331.6 K to 327.7 K (-1.18 %) |
Mar 18 2019 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 40.48 | 3,200 | 129,536 | 331,637 | 334.8 K to 331.6 K (-0.96 %) |
Mar 18 2019 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 39.10 | 700 | 27,370 | 334,837 | 335.5 K to 334.8 K (-0.21 %) |
Mar 01 2019 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 36.13 | 3,900 | 140,907 | 335,537 | 339.4 K to 335.5 K (-1.15 %) |
Mar 01 2019 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 36.20 | 3,700 | 133,940 | 339,437 | 343.1 K to 339.4 K (-1.08 %) |
Mar 01 2019 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 35.22 | 200 | 7,044 | 343,137 | 343.3 K to 343.1 K (-0.06 %) |
Feb 19 2019 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Payment of Exercise | F | 40.45 | 1,176 | 47,569 | 332,243 | 333.4 K to 332.2 K (-0.35 %) |
Feb 12 2019 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 39.01 | 3,900 | 152,139 | 342,138 | 346 K to 342.1 K (-1.13 %) |
Feb 12 2019 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 38.52 | 3,900 | 150,228 | 346,038 | 349.9 K to 346 K (-1.11 %) |
Feb 12 2019 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Payment of Exercise | F | 38.49 | 20,324 | 782,271 | 334,618 | 354.9 K to 334.6 K (-5.73 %) |
Feb 08 2019 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Payment of Exercise | F | 0.00 | 24,683 | 0 | 375,611 | 400.3 K to 375.6 K (-6.17 %) |
Jan 25 2019 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 35.82 | 430 | 15,403 | 296,452 | 296.9 K to 296.5 K (-0.14 %) |
Jan 25 2019 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 34.98 | 3,470 | 121,381 | 296,882 | 300.4 K to 296.9 K (-1.16 %) |
Jan 25 2019 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 36.58 | 100 | 3,658 | 300,352 | 300.5 K to 300.4 K (-0.03 %) |
Jan 25 2019 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 35.59 | 800 | 28,472 | 300,452 | 301.3 K to 300.5 K (-0.27 %) |
Jan 25 2019 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 34.84 | 3,000 | 104,520 | 301,252 | 304.3 K to 301.3 K (-0.99 %) |
Jan 10 2019 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 34.50 | 2,200 | 75,900 | 4,078 | 6.3 K to 4.1 K (-35.04 %) |
Jan 10 2019 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 33.93 | 1,700 | 57,681 | 6,278 | 8 K to 6.3 K (-21.31 %) |
Jan 10 2019 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 35.16 | 2,000 | 70,320 | 7,978 | 10 K to 8 K (-20.04 %) |
Jan 10 2019 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 34.51 | 1,900 | 65,569 | 9,978 | 11.9 K to 10 K (-16.00 %) |
Dec 28 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 35.40 | 500 | 17,700 | 11,878 | 12.4 K to 11.9 K (-4.04 %) |
Dec 28 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 34.60 | 3,400 | 117,640 | 12,378 | 15.8 K to 12.4 K (-21.55 %) |
Dec 28 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 34.19 | 653 | 22,326 | 15,778 | 16.4 K to 15.8 K (-3.97 %) |
Dec 28 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 32.82 | 3,247 | 106,567 | 16,431 | 19.7 K to 16.4 K (-16.50 %) |
Dec 13 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 42.75 | 3,900 | 166,725 | 19,678 | 23.6 K to 19.7 K (-16.54 %) |
Dec 13 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 42.56 | 3,900 | 165,984 | 23,578 | 27.5 K to 23.6 K (-14.19 %) |
Nov 29 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 42.26 | 2,500 | 105,650 | 27,478 | 30 K to 27.5 K (-8.34 %) |
Nov 29 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 41.13 | 1,400 | 57,582 | 29,978 | 31.4 K to 30 K (-4.46 %) |
Nov 29 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 39.54 | 1,200 | 47,448 | 31,378 | 32.6 K to 31.4 K (-3.68 %) |
Nov 29 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 38.65 | 2,700 | 104,355 | 32,578 | 35.3 K to 32.6 K (-7.65 %) |
Nov 15 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 35.49 | 2,800 | 99,372 | 35,278 | 38.1 K to 35.3 K (-7.35 %) |
Nov 15 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 34.67 | 1,100 | 38,137 | 38,078 | 39.2 K to 38.1 K (-2.81 %) |
Nov 15 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 34.51 | 600 | 20,706 | 39,178 | 39.8 K to 39.2 K (-1.51 %) |
Nov 15 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 33.89 | 3,300 | 111,837 | 39,778 | 43.1 K to 39.8 K (-7.66 %) |
Oct 23 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 35.18 | 800 | 28,144 | 43,078 | 43.9 K to 43.1 K (-1.82 %) |
Oct 23 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 34.39 | 1,700 | 58,463 | 43,878 | 45.6 K to 43.9 K (-3.73 %) |
Oct 23 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 33.17 | 1,400 | 46,438 | 45,578 | 47 K to 45.6 K (-2.98 %) |
Oct 23 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 34.26 | 795 | 27,237 | 46,978 | 47.8 K to 47 K (-1.66 %) |
Oct 23 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 33.66 | 3,105 | 104,514 | 47,773 | 50.9 K to 47.8 K (-6.10 %) |
Oct 05 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 41.00 | 100 | 4,100 | 50,878 | 51 K to 50.9 K (-0.20 %) |
Oct 05 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 40.25 | 1,900 | 76,475 | 50,978 | 52.9 K to 51 K (-3.59 %) |
Oct 05 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 39.58 | 1,900 | 75,202 | 52,878 | 54.8 K to 52.9 K (-3.47 %) |
Oct 05 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 41.34 | 1,300 | 53,742 | 54,778 | 56.1 K to 54.8 K (-2.32 %) |
Oct 05 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 40.09 | 2,600 | 104,234 | 56,078 | 58.7 K to 56.1 K (-4.43 %) |
Sep 25 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Payment of Exercise | F | 39.85 | 79,328 | 3,161,221 | 733,285 | 812.6 K to 733.3 K (-9.76 %) |
Sep 20 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 39.99 | 3,900 | 155,961 | 58,678 | 62.6 K to 58.7 K (-6.23 %) |
Sep 20 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 39.62 | 3,900 | 154,518 | 62,578 | 66.5 K to 62.6 K (-5.87 %) |
Sep 10 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 40.23 | 1,827 | 73,500 | 66,478 | 68.3 K to 66.5 K (-2.67 %) |
Sep 10 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 39.74 | 2,073 | 82,381 | 68,305 | 70.4 K to 68.3 K (-2.95 %) |
Sep 10 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 39.42 | 1,120 | 44,150 | 70,378 | 71.5 K to 70.4 K (-1.57 %) |
Sep 10 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 38.45 | 2,780 | 106,891 | 71,498 | 74.3 K to 71.5 K (-3.74 %) |
Aug 22 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 36.69 | 3,900 | 143,091 | 74,278 | 78.2 K to 74.3 K (-4.99 %) |
Aug 22 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 36.04 | 3,900 | 140,556 | 78,178 | 82.1 K to 78.2 K (-4.75 %) |
Aug 07 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 37.75 | 300 | 11,325 | 82,078 | 82.4 K to 82.1 K (-0.36 %) |
Aug 07 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 37.35 | 3,600 | 134,460 | 82,378 | 86 K to 82.4 K (-4.19 %) |
Aug 07 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 37.48 | 3,900 | 146,172 | 85,978 | 89.9 K to 86 K (-4.34 %) |
Jul 30 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 37.53 | 1,700 | 63,801 | 89,878 | 91.6 K to 89.9 K (-1.86 %) |
Jul 30 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 36.55 | 2,200 | 80,410 | 91,578 | 93.8 K to 91.6 K (-2.35 %) |
Jul 30 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 39.45 | 100 | 3,945 | 93,778 | 93.9 K to 93.8 K (-0.11 %) |
Jul 30 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 39.02 | 3,800 | 148,276 | 93,878 | 97.7 K to 93.9 K (-3.89 %) |
Jul 11 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 40.54 | 6,100 | 247,294 | 97,678 | 103.8 K to 97.7 K (-5.88 %) |
Jul 11 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 39.93 | 22,300 | 890,439 | 103,778 | 126.1 K to 103.8 K (-17.69 %) |
Jul 11 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 40.63 | 2,141 | 86,989 | 126,078 | 128.2 K to 126.1 K (-1.67 %) |
Jul 11 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 39.88 | 27,859 | 1,111,017 | 128,219 | 156.1 K to 128.2 K (-17.85 %) |
Jun 27 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 39.40 | 500 | 19,700 | 156,078 | 156.6 K to 156.1 K (-0.32 %) |
Jun 27 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 37.57 | 1,500 | 56,355 | 156,578 | 158.1 K to 156.6 K (-0.95 %) |
Jun 27 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 40.79 | 1,700 | 69,343 | 158,078 | 159.8 K to 158.1 K (-1.06 %) |
Jun 27 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 40.01 | 2,700 | 108,027 | 159,778 | 162.5 K to 159.8 K (-1.66 %) |
Jun 06 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 48.59 | 1,000 | 48,590 | 162,478 | 163.5 K to 162.5 K (-0.61 %) |
Jun 06 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 47.69 | 1,500 | 71,535 | 163,478 | 165 K to 163.5 K (-0.91 %) |
Jun 06 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 46.53 | 1,900 | 88,407 | 164,978 | 166.9 K to 165 K (-1.14 %) |
Jun 06 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 50.27 | 1,200 | 60,324 | 166,878 | 168.1 K to 166.9 K (-0.71 %) |
Jun 06 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 49.51 | 3,200 | 158,432 | 168,078 | 171.3 K to 168.1 K (-1.87 %) |
May 22 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 50.88 | 4,400 | 223,872 | 171,278 | 175.7 K to 171.3 K (-2.50 %) |
May 22 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 53.64 | 900 | 48,276 | 175,678 | 176.6 K to 175.7 K (-0.51 %) |
May 22 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 52.83 | 2,000 | 105,660 | 176,578 | 178.6 K to 176.6 K (-1.12 %) |
May 22 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 51.67 | 1,500 | 77,505 | 178,578 | 180.1 K to 178.6 K (-0.83 %) |
May 10 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 40.98 | 2,200 | 90,156 | 180,078 | 182.3 K to 180.1 K (-1.21 %) |
May 10 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 40.08 | 2,200 | 88,176 | 182,278 | 184.5 K to 182.3 K (-1.19 %) |
May 10 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 39.50 | 3,100 | 122,450 | 184,478 | 187.6 K to 184.5 K (-1.65 %) |
May 10 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 38.35 | 1,300 | 49,855 | 187,578 | 188.9 K to 187.6 K (-0.69 %) |
Apr 12 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 43.69 | 1,200 | 52,428 | 197,678 | 198.9 K to 197.7 K (-0.60 %) |
Apr 12 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 42.63 | 3,200 | 136,416 | 198,878 | 202.1 K to 198.9 K (-1.58 %) |
Apr 12 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 41.37 | 400 | 16,548 | 202,078 | 202.5 K to 202.1 K (-0.20 %) |
Apr 12 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 40.77 | 4,000 | 163,080 | 202,478 | 206.5 K to 202.5 K (-1.94 %) |
Mar 27 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 38.40 | 200 | 7,680 | 206,478 | 206.7 K to 206.5 K (-0.10 %) |
Mar 27 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 37.68 | 1,500 | 56,520 | 206,678 | 208.2 K to 206.7 K (-0.72 %) |
Mar 27 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 36.63 | 2,700 | 98,901 | 208,178 | 210.9 K to 208.2 K (-1.28 %) |
Mar 27 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 41.12 | 1,200 | 49,344 | 210,878 | 212.1 K to 210.9 K (-0.57 %) |
Mar 27 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 39.72 | 3,200 | 127,104 | 212,078 | 215.3 K to 212.1 K (-1.49 %) |
Mar 19 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 42.59 | 1,300 | 55,367 | 215,278 | 216.6 K to 215.3 K (-0.60 %) |
Mar 19 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 41.75 | 3,100 | 129,425 | 216,578 | 219.7 K to 216.6 K (-1.41 %) |
Mar 19 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 42.95 | 1,600 | 68,720 | 219,678 | 221.3 K to 219.7 K (-0.72 %) |
Mar 19 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 41.87 | 2,800 | 117,236 | 221,278 | 224.1 K to 221.3 K (-1.25 %) |
Mar 14 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 46.65 | 300 | 13,995 | 224,078 | 224.4 K to 224.1 K (-0.13 %) |
Mar 14 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 46.17 | 700 | 32,319 | 224,378 | 225.1 K to 224.4 K (-0.31 %) |
Feb 22 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 45.00 | 1,400 | 63,000 | 225,078 | 226.5 K to 225.1 K (-0.62 %) |
Feb 22 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 44.03 | 1,600 | 70,448 | 226,478 | 228.1 K to 226.5 K (-0.70 %) |
Feb 22 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 42.74 | 1,600 | 68,384 | 228,078 | 229.7 K to 228.1 K (-0.70 %) |
Feb 22 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 44.55 | 2,911 | 129,685 | 229,678 | 232.6 K to 229.7 K (-1.25 %) |
Feb 22 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 43.60 | 1,589 | 69,280 | 232,589 | 234.2 K to 232.6 K (-0.68 %) |
Feb 22 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 45.28 | 8,700 | 393,936 | 234,178 | 242.9 K to 234.2 K (-3.58 %) |
Feb 20 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Option Exercise | M | 0.00 | 3,938 | 0 | 0 | |
Feb 20 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Buy | M | 0.00 | 3,938 | 0 | 812,613 | 808.7 K to 812.6 K (+0.49 %) |
Feb 20 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 48.43 | 300 | 14,529 | 242,878 | 243.2 K to 242.9 K (-0.12 %) |
Feb 20 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 47.91 | 5,100 | 244,341 | 243,178 | 248.3 K to 243.2 K (-2.05 %) |
Feb 20 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 46.55 | 1,600 | 74,480 | 248,278 | 249.9 K to 248.3 K (-0.64 %) |
Feb 20 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 45.44 | 3,000 | 136,320 | 249,878 | 252.9 K to 249.9 K (-1.19 %) |
Feb 20 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 48.25 | 300 | 14,475 | 252,878 | 253.2 K to 252.9 K (-0.12 %) |
Feb 20 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 47.56 | 4,767 | 226,719 | 253,178 | 257.9 K to 253.2 K (-1.85 %) |
Feb 20 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 46.71 | 2,433 | 113,645 | 257,945 | 260.4 K to 257.9 K (-0.93 %) |
Feb 20 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 45.58 | 2,500 | 113,950 | 260,378 | 262.9 K to 260.4 K (-0.95 %) |
Feb 14 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 49.25 | 3,100 | 152,675 | 262,878 | 266 K to 262.9 K (-1.17 %) |
Feb 14 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 48.42 | 5,800 | 280,836 | 265,978 | 271.8 K to 266 K (-2.13 %) |
Feb 14 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 46.94 | 1,000 | 46,940 | 271,778 | 272.8 K to 271.8 K (-0.37 %) |
Feb 14 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 45.05 | 100 | 4,505 | 272,778 | 272.9 K to 272.8 K (-0.04 %) |
Feb 14 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 45.10 | 10,000 | 451,000 | 272,878 | 282.9 K to 272.9 K (-3.54 %) |
Feb 12 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 41.70 | 300 | 12,510 | 282,878 | 283.2 K to 282.9 K (-0.11 %) |
Feb 12 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 40.79 | 400 | 16,316 | 283,178 | 283.6 K to 283.2 K (-0.14 %) |
Feb 12 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 38.68 | 400 | 15,472 | 283,578 | 284 K to 283.6 K (-0.14 %) |
Feb 12 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 37.43 | 1,100 | 41,173 | 283,978 | 285.1 K to 284 K (-0.39 %) |
Feb 12 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 36.59 | 2,200 | 80,498 | 285,078 | 287.3 K to 285.1 K (-0.77 %) |
Feb 12 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 37.15 | 4,400 | 163,460 | 287,278 | 291.7 K to 287.3 K (-1.51 %) |
Feb 08 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Option Exercise | A | 35.80 | 130,000 | 4,654,000 | 130,000 | |
Feb 08 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Grant | A | 0.00 | 65,000 | 0 | 808,675 | 743.7 K to 808.7 K (+8.74 %) |
Jan 29 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 36.98 | 2,100 | 77,658 | 291,678 | 293.8 K to 291.7 K (-0.71 %) |
Jan 29 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 36.54 | 6,100 | 222,894 | 293,778 | 299.9 K to 293.8 K (-2.03 %) |
Jan 29 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 35.46 | 1,100 | 39,006 | 299,878 | 301 K to 299.9 K (-0.37 %) |
Jan 29 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 34.68 | 200 | 6,936 | 300,978 | 301.2 K to 301 K (-0.07 %) |
Jan 29 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 34.23 | 8,400 | 287,532 | 301,178 | 309.6 K to 301.2 K (-2.71 %) |
Jan 29 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 33.22 | 1,400 | 46,508 | 309,578 | 311 K to 309.6 K (-0.45 %) |
Jan 24 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 34.99 | 2,200 | 76,978 | 310,978 | 313.2 K to 311 K (-0.70 %) |
Jan 24 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 34.40 | 4,100 | 141,040 | 313,178 | 317.3 K to 313.2 K (-1.29 %) |
Jan 24 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 33.20 | 8,100 | 268,920 | 317,278 | 325.4 K to 317.3 K (-2.49 %) |
Jan 24 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 36.15 | 8,516 | 307,853 | 325,378 | 333.9 K to 325.4 K (-2.55 %) |
Jan 24 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 35.45 | 15,084 | 534,728 | 333,894 | 349 K to 333.9 K (-4.32 %) |
Jan 24 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 34.05 | 500 | 17,025 | 348,978 | 349.5 K to 349 K (-0.14 %) |
Jan 24 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 34.04 | 2,000 | 68,080 | 349,478 | 351.5 K to 349.5 K (-0.57 %) |